Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Wyss Institute Unveils Portable, Low-Cost Biomolecular Manufacturing Biodetection September 26, 2016 …
Phase I Study Planned for Multivalent Vaccine to Combat Ebola, Marburg Industry News September 12, 2016 …
